The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Neuroinflammatory processes in Parkinson's disease
Abstract
Parkinson's disease (PD) is a movement disorder characterized by the progressive degeneration of dopaminergic neurons in the midbrain. To date, its cause remains unknown and the mechanism of nerve cell death uncertain. Apart from the massive loss of dopaminergic neurons, PD brains also show a conspicuous glial reaction together with signs of a neuroinflammatory reaction manifested by elevated cytokine levels and upregulation of inflammatory-associated factors such as cyclooxygenase-2 and inducible nitric oxide synthase. Mounting evidence also suggests a possible deleterious effect of these neuroinflammatory processes in experimental models of the disease. We propose that, in PD, neuroinflammation plays a role in the cascade of events leading to nerve cell death, thus propagating the neurodegenerative process. In this review, we summarize and discuss the latest findings regarding neuroinflammatory aspects in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., & Beckman, J. S. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90431-u · Cited by 1,495
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
Hayday, A. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.975 · Cited by 1,136
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Dawson, V., Dawson, T., Bartley, D., Uhl, G., & Snyder, S. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02651.1993 · Cited by 1,014
Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 715
Self-citationHunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Self-citationNitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Self-citationImmunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Self-citationProtein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
Failure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503
Brain microglia constitutively express β-2 integrins
Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430
Schulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020936.x · Cited by 417
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Self-citationBiosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., & Kühn, L. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06038.x · Cited by 401
Kurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379
Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain Injury
Sullivan, P. G., Thompson, M. B., & Scheff, S. W. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7197 · Cited by 344
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Hartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270
Self-citationPennathur, S., Jackson-Lewis, V., Przedborski, S., & Heinecke, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34621 · Cited by 265
Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247
Grünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Pantopoulos, K., & Hentze, M. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1267 · Cited by 220
Blood vessels change in the mesencephalon of patients with Parkinson's disease
Faucheux, B. A., Agid, Y., Hirsch, E. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218
Self-citationFarkas, E., De Jong, G. I., de Vos, R. A. I., Jansen Steur, E. N. H., & Luiten, P. G. M. (2000) · Acta Neuropathologica · doi:10.1007/s004010000195 · Cited by 217
Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice
Aubin, N., Curet, O., Deffois, A., & Carter, C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041635.x · Cited by 214
Sphingomyelin breakdown and cell fate
TESTI, R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10056-6 · Cited by 208
Rascol, O., Brooks, D. J., Brunt, E. R., Korczyn, A. D., Poewe, W. H., & Stocchi, F. (1998) · Movement Disorders · doi:10.1002/mds.870130111 · Cited by 186
Liu, J., Zhao, M. L., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170
Ijzermans, J. N. M., & Marquet, R. L. (1989) · Immunobiology · doi:10.1016/s0171-2985(89)80049-x · Cited by 153
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease
Hirsch, É. C., Hunot, S., Faucheux, B. A., Agid, Y., Mizuno, Y., Mochizuki, H., Tatton, W. G., Tatton, N. A., & Olanow, W. C. (1999) · Movement Disorders · Cited by 153
Self-citationInducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
Ding, M., Pierre, B. A. S., Parkinson, J. F., Medberry, P. S., Wong, J. L., Rogers, N. E., Ignarro, L. J., & Merrill, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11327 · Cited by 147
Peterson, P. K., Hu, S., Anderson, W. R., & Chao, C. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.457 · Cited by 143
Increased cerebrospinal fluid concentration of nitrite in Parkinsonʼs disease
Qureshi, G. A., Baig, S., Bednar, I., Södersten, P., Forsberg, G., & Sidén, Å. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00013 · Cited by 135
Increase in Peripheral CD4 Bright+ CD8 Dull+ T Cells in Parkinson Disease
Hisanaga, K., 浅黄美沙, Itoyama, Y., & Iwasaki, Y. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1580 · Cited by 131
Experimental Destruction of Substantia Nigra Initiated by Parkinson Disease Immunoglobulins
Chen, S., Le, W.-D., Xie, W., Alexianu, M. E., Engelhardt, J. I., Siklós, L., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.8.1075 · Cited by 130
Rockwell, P., Yuan, H., Magnusson, R., & Figueiredo-Pereira, M. E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1646 · Cited by 130
Iron metabolism and Parkinson's disease.
Hirsch, É. C., & Faucheux, B. A. (1998) · PubMed · Cited by 124
González, M. V., Jiménez, B., Berciano, M. T., González‐Sancho, J. M., Caelles, C., Lafarga, M., & Múñoz, A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1199 · Cited by 123
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 119
A rat model of Parkinson's disease induced by Japanese encephalitis virus.
Ogata, A., Tashiro, K., Nukuzuma, S., Nagashima, K., & Hall, W. (1997) · Journal of Neurovirology · doi:10.3109/13550289709015803 · Cited by 110
γδ+ T cells are increased in patients with Parkinson's disease
Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Olsson, T. P., & Link, H. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90154-6 · Cited by 108
Postencephalitic parkinsonism – a review
Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 108
Kitamura, Y., Itano, Y., Kubo, T., & Nomura, Y. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90049-3 · Cited by 96
Mogi, M., Togari, A., Tanaka, K., Ogawa, N., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00388-2 · Cited by 85
Dexamethasone pre-treatment interferes with apoptotic death in glioma cells
Gorman, A. M., Hirt, U. A., Orrenius, S., & Ceccatelli, S. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00565-5 · Cited by 84
Neuronal interferon‐γ immunoreactive molecule: Bioactivities and purification
Olsson, T. P., Bakhiet, M., Höjeberg, B., Ljungdahl, Å., Kelič, S., Edlund, C., Kristensson, K., & van der Meide, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240205 · Cited by 84
INTERFERON γ GENE EXPRESSION IN RAT CENTRAL NERVOUS SYSTEM GLIAL CELLS
Simone, R. D., Levi, G., & Aloisi, F. (1998) · Cytokine · doi:10.1006/cyto.1997.0314 · Cited by 83
The iron-responsive element binding protein: a target for synaptic actions of nitric oxide.
Jaffrey, S. R., Cohen, N. A., Rouault, T. A., Klausner, R. D., & Snyder, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12994 · Cited by 78
Mogi, M., Togari, A., Ogawa, M., Ikeguchi, K., Shizuma, N., Dong-shen, F., Nakano, I., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00427-3 · Cited by 77
Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation
Rowe, D. B., Le, W., Smith, R. G., & Appel, S. H. (1998) · Journal of Neuroscience Research · Cited by 61
Janabi, N., Chabrier, S., & Tardieu, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2129 · Cited by 60
Anatomy and Pathology of the Basal Ganglia
McGeer, P. L., McGeer, E. G., Itagaki, S., & Mizukawa, K. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037756 · Cited by 56
Matsuura, K., Makino, H., & Ogawa, N. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6575 · Cited by 55
Chae, H., Chae, S., Kang, J. S., Bang, B.-G., Cho, S. B., Park, R., So, H. S., Kim, Y. K., Kim, H. M., & Kim, H. (2000) · Endocrinology · doi:10.1210/endo.141.8.7604 · Cited by 53
Carvey, P. M., McRae‐Degueurce, A., Lint, T. F., Ptak, L. R., Lo, E. S., Goetz, C., & Klawans, H. L. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.53 · Cited by 47
A possible role of influenza A virus infection for Parkinson's disease.
Takahashi, M., & Yamada, T. (2001) · PubMed · Cited by 40
Kiefer, R., Haas, C. A., & Kreutzberg, G. W. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90270-x · Cited by 37
Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions
McRae‐Degueurce, A., GOTTFRIES, C. ‐., Karlsson, I., Svennerholm, L., & Dahlström, A. B. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07821.x · Cited by 37
Defazio, G., Toso, R. D., Benvegnuù, D., MINOZZI, M. C., Cananzi, A. R., & Leon, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91541-5 · Cited by 33
Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease
Fiszer, U., Fredrikson, S., & Członkowska, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00002-0 · Cited by 33
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
Boireau, A., Bordier, F., Dubédat, P., Pény, C., & Impérato, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00685-x · Cited by 31
Experimental autoimmune nigral damage in guinea pigs
Le, W. D., Engelhardt, J., Xie, W., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00160-p · Cited by 28
Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs
Appel, S. H., Le, W., Tajti, J., Haverkamp, L. J., & Engelhardt, J. I. (1992) · Annals of Neurology · doi:10.1002/ana.410320403 · Cited by 28
ROLE OF CD23 IN ASTROCYTES INFLAMMATORY REACTION DURING HIV-1 RELATED ENCEPHALITIS
Dugas, N., Lacroix, C., Kilchherr, E., Delfraissy, J., & Tardieu, M. (2001) · Cytokine · doi:10.1006/cyto.2001.0896 · Cited by 26
Antibody-dependent cell-mediated cytotoxicity (ADCC) in Parkinson's disease
Bokor, M., Faragó, A., Garam, T., Malatinszky, G., & Schnabel, R. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90065-7 · Cited by 21
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Self-citationEtiology and pathogenesis of Parkinson's disease
Schapira, A. H., & Jenner, P. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 657
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., & Guerri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0976-10.2010 · Cited by 579
Metadata
- Authors
- Hunot, S., & Hirsch, E. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003
- Volume
- 53
- Issue
- S3
- Pages
- S49-S60
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2120812632
- Cited by
- 398
- References
- 77
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.